INCENDIA THERAPEUTICS
LIVE

Serial Number

98311415

Owner

Incendia Therapeutics Inc.

Attorney

IAN W. GILLIES

Filing Date

Dec 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INCENDIA THERAPEUTICS Trademark

Serial Number: 98311415

INCENDIA THERAPEUTICS is a trademark filed by Incendia Therapeutics Inc. on December 12, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Incendia Therapeutics Inc. (3 trademarks)

40 Guest St.
Boston, MA 02135

Entity Type: 03

Trademark Details

Filing Date

December 12, 2023

Registration Date

Not Registered

Goods & Services

Monoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers

Drug discovery services for the discovery of monoclonal antibody-containing drugs for the treatment of immune-excluded tumors, provided through a computational platform engine using biology and chemistry analytics in the field of recalcitrant cancers

Monoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 24, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 24, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2025 CRFA
ASSIGNED TO LIE
Jul 22, 2025 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 17, 2025 ERFR
EX PARTE APPEAL-INSTITUTED
Jul 17, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 17, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jul 17, 2025 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 14, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 14, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 22, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 22, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 22, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 9, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 9, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 26, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2024 NWOS
NEW APPLICATION ENTERED
Dec 12, 2023 NWAP